Lyra Therapeutics (LYRA) Retained Earnings (2021 - 2025)
Historic Retained Earnings for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to -$426.8 million.
- Lyra Therapeutics' Retained Earnings fell 837.69% to -$426.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$426.8 million, marking a year-over-year decrease of 837.69%. This contributed to the annual value of -$404.8 million for FY2024, which is 3000.92% down from last year.
- As of Q3 2025, Lyra Therapeutics' Retained Earnings stood at -$426.8 million, which was down 837.69% from -$420.8 million recorded in Q2 2025.
- In the past 5 years, Lyra Therapeutics' Retained Earnings ranged from a high of -$157.7 million in Q1 2021 and a low of -$426.8 million during Q3 2025
- Its 5-year average for Retained Earnings is -$291.4 million, with a median of -$280.5 million in 2023.
- Per our database at Business Quant, Lyra Therapeutics' Retained Earnings plummeted by 3614.0% in 2024 and then tumbled by 837.69% in 2025.
- Over the past 5 years, Lyra Therapeutics' Retained Earnings (Quarter) stood at -$193.4 million in 2021, then dropped by 28.58% to -$248.7 million in 2022, then fell by 25.21% to -$311.4 million in 2023, then crashed by 30.01% to -$404.8 million in 2024, then dropped by 5.44% to -$426.8 million in 2025.
- Its last three reported values are -$426.8 million in Q3 2025, -$420.8 million for Q2 2025, and -$413.3 million during Q1 2025.